Company Research Report: Paradigm Health, Inc.

Company Overview

• Name: Paradigm Health, Inc.

• Mission: To create equitable access to the best possible care for any patient, anywhere, by building a new, efficient clinical research ecosystem.

• Founded By: No information is available.

• Key People:

• Kent Thoelke, Chief Executive Officer

• Jonathan Hirsch, Chief Strategy & Growth Officer

• Jay Trepanier, Chief Financial Officer

• Elijah Meerson, Chief Technology Officer

• Michelle Lee, Chief Operating Officer

• Headquarters: No information is available.

• Number of Employees: No information is available.

• Revenue: No information is available.

• Known For: Paradigm is known for its innovative approach to clinical trials, focusing on efficiency, reducing physician burden, and expanding patient access.

Products

• Clinical Trial Platform:

• Description: A robust clinical trial platform designed to improve operations for care providers by matching trials to patient populations and providing logistical support.

• Key Features:

• Seamless integration into provider workflows.

• Automated data entry using electronic medical records (EMR).

• Leading-edge technology for patient screening and recruitment.

• End-to-end logistical support for trial operations.

Recent Developments

• New Partnerships:

• A strategic partnership with Sheba Medical Center and ARC Innovation in Israel to transform clinical trials with AI-driven technology and expand global trials.

• Collaboration with Fujitsu to reduce the administrative burden of clinical trials in Japan and expand patient access.

• New Product Features:

• Deployment of AI and machine learning models, improving screening accuracy by 10% over state-of-the-art methods with reduced clinician time.

• Enhanced patient recruitment capabilities, enabling earlier screening and increasing enrollment rates.

• Case Studies:

• Altru Health System: Increased patient enrollment in clinical trials from 4% to 11%, significantly impacting rural communities by providing access to trials as a care option.

• Highlands Oncology: Increased clinical trial participation by 45%, achieved through deploying best practices and technology, impacting patient care positively.